Schizophrenia Research
Volume 81, Issue 1 , Pages 1-15, 1 January 2006

One-year double-blind study of the neurocognitive efficacy of olanzapine, risperidone, and haloperidol in schizophrenia☆

  • Richard S.E. Keefe

      Affiliations

    • Department of Psychiatry and Behavioral Sciences, Duke University School of Medicine, Durham, NC 27710, United States
    • Corresponding Author InformationCorresponding author. Tel.: +1 919 684 4306; fax: +1 919 684 2632.
    • ,
  • Carrie A. Young

      Affiliations

    • Lilly Research Laboratories, Indianapolis, IN US 46285, United States
    • ,
  • Stephanie L. Rock

      Affiliations

    • Lilly Research Laboratories, Indianapolis, IN US 46285, United States
    • ,
  • Scot E. Purdon

      Affiliations

    • Department of Psychiatry, University of Alberta, CHA-ANE, Box 307, Edmonton, Alberta, Canada T5J 2J7
    • ,
  • James M. Gold

      Affiliations

    • Maryland Psychiatric Research Center, University of Maryland Baltimore, School of Medicine, P.O. Box 21247, Baltimore, MD 21228, USA
    • ,
  • Alan Breier

      Affiliations

    • Lilly Research Laboratories, Indianapolis, IN US 46285, United States
    • ,
  • HGGN Study Group

      Affiliations

    • Consisted of all authors and others, who participated in the design and execution of HGGN study partially funded by Lilly Research Laboratories.

Received 21 February 2005; received in revised form 27 July 2005; accepted 29 July 2005.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

☆ Colleogium Internationale Neuro-Psychopharmacologicum annual meeting June 23–27, 2002; Montreal, Canada; European College on Neuropsychpharmacology annual meeting October 5–9, 2002; Barcelona, Spain; American College Of Neuropsychopharmacology annual meeting December 8–12, 2002; San Juan, Puerto Rico; International Congress on Schizophrenia Research annual meeting March 29–April 2, 2003; Colorado Springs, CO, USA.

PII: S0920-9964(05)00355-5

doi:10.1016/j.schres.2005.07.038

Schizophrenia Research
Volume 81, Issue 1 , Pages 1-15, 1 January 2006

Article Tools

* Image Usage & Resolution